Kaveesha Bodiyabadu

The parC mutation G248T (S83I), and concurrent gyrA mutations, are associated with moxifloxacin and sitafloxacin treatment failure for Mycoplasma genitalium

Gerald L. Murray, Kaveesha Bodiyabadu, Jennifer Danielewski et al. · The Journal of Infectious Diseases · 2019 · 59 citations

Are <i>Mycoplasma hominis</i>, <i>Ureaplasma urealyticum</i> and <i>Ureaplasma parvum</i> Associated With Specific Genital Symptoms and Clinical Signs in Nonpregnant Women?

Erica L. Plummer, Lenka A. Vodstrcil, Kaveesha Bodiyabadu et al. · Clinical Infectious Diseases · 2021 · 47 citations

Combination Therapy for <i>Mycoplasma genitalium</i>, and New Insights Into the Utility of <i>parC</i> Mutant Detection to Improve Cure

Lenka A. Vodstrcil, Erica L. Plummer, Michelle Doyle et al. · Clinical Infectious Diseases · 2022 · 47 citations

<i>parC</i> Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure

Gerald L. Murray, Kaveesha Bodiyabadu, Lenka A. Vodstrcil et al. · Antimicrobial Agents and Chemotherapy · 2022 · 46 citations · Full text

<i>gyrA</i> Mutations in <i>Mycoplasma genitalium</i> and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy

Gerald L. Murray, Erica L. Plummer, Kaveesha Bodiyabadu et al. · Clinical Infectious Diseases · 2023 · 42 citations · Full text